Vishal Patel, MD, FAAD, FACMS

Cemiplimab is revolutionizing treatment for high-risk cutaneous squamous cell carcinoma, bridging gaps in care and improving patient outcomes.

Vishal A. Patel, MD, discusses cemiplimab's FDA approval as a groundbreaking adjuvant therapy for high-risk cutaneous squamous cell carcinoma patients.

Treatment decisions are increasingly guided by patient values, preferences, and quality-of-life considerations.

Panelists discuss how advanced basal cell carcinoma (BCC) management requires a nuanced approach, emphasizing the importance of early detection, multidisciplinary collaboration, personalized treatment strategies, and ongoing patient monitoring to optimize outcomes and quality of life.

Panelists discuss how setting long-term treatment goals for basal cell carcinoma (BCC) patients involves balancing factors such as disease control, quality of life, and potential adverse reactions to create personalized management plans that address both immediate concerns and future outcomes.

Panelists discuss how a complex case of advanced basal cell carcinoma (BCC) demonstrates the necessity for collaborative care across multiple specialties, highlighting the importance of tailored treatment strategies and coordinated management to achieve the best possible patient outcomes.

Panelists discuss how a multidisciplinary approach involving dermatologists, surgeons, radiation oncologists, and medical oncologists is crucial for optimal decision-making and management of complex basal cell carcinoma (BCC) cases, ensuring comprehensive care and improved patient outcomes.

Panelists discuss how advanced basal cell carcinoma (BCC) presents unique treatment challenges and examine recent developments that show promise for improving outcomes in patients with this aggressive form of skin cancer.

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide initial impressions of the case and discuss the use of immune checkpoint inhibitors.

Sherrif F. Ibrahim, MD, PhD, presents the case of a 49-year-old White woman with neglected large basal cell carcinoma.

Expert dermatologists discuss future directions for the management of basal cell carcinoma.

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, discuss the impact of immune checkpoint inhibitors used in BCC.

Experts in dermatology discuss the treatment landscape for BCC.

Drs Sherrif F. Ibrahim and Vishal Patel discuss the importance of a multidisciplinary team in the treatment of BCC as well as best practices for preventing advanced BCC.

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide an overview of BCC and discuss disease burden.